Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.24.1.u1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid In Capital
Retained Earnings
Beginning Balance at Dec. 31, 2022 $ 801,128 $ 3,072 $ 783,579 $ 14,477
Beginning Balance , Shares at Dec. 31, 2022   306,626,530    
Stock-based compensation expense 5,361   5,361  
Vesting of restricted stock units, shares   4,296    
Exercise of stock options 1,116 $ 15 1,101  
Exercise of stock options , shares   1,471,021    
Net income 21,136     21,136
Ending Balance at Mar. 31, 2023 828,741 $ 3,087 790,041 35,613
Ending Balance , Shares at Mar. 31, 2023   308,101,847    
Beginning Balance at Dec. 31, 2023 915,035 $ 3,157 817,271 94,607
Beginning Balance , Shares at Dec. 31, 2023   315,192,401    
Stock-based compensation expense 6,246   6,246  
Vesting of restricted stock units   $ 1 (1)  
Vesting of restricted stock units, shares   139,409    
Exercise of stock options $ 746 $ 42 704  
Exercise of stock options , shares 4,116,291 4,116,291    
Shares repurchased $ (9,940) $ (16) (9,924)  
Shares repurchased, shares   (1,613,019)    
Net income 16,637     16,637
Ending Balance at Mar. 31, 2024 $ 928,724 $ 3,184 $ 814,296 $ 111,244
Ending Balance , Shares at Mar. 31, 2024   317,835,082